About Synthex Labs
Synthex Labs is a company based in San Francisco (United States) founded in 2016.. Synthex Labs has raised $10.37 million across 3 funding rounds from investors including IndieBio. The company has 15 employees as of December 31, 2024. Synthex Labs offers products and services including Tor FLEx Platform, ToRPPIDO, and ToRNeDO. Synthex Labs operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter San Francisco, United States
- Employees 15 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synthex, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.37 M (USD)
in 3 rounds
-
Latest Funding Round
$5.18 M (USD), Series A
Dec 29, 2023
- Investors
-
Employee Count
15
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synthex Labs
Synthex Labs offers a comprehensive portfolio of products and services, including Tor FLEx Platform, ToRPPIDO, and ToRNeDO. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Engineers cells to identify drugs for challenging protein targets.
Supports oncology drug development through functional selection.
Facilitates exploration of novel drug mechanisms in pipelines.
Unlock access to complete
Unlock access to complete
Funding Insights of Synthex Labs
Synthex Labs has successfully raised a total of $10.37M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.18 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $5.2M
-
First Round
First Round
(15 Oct 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Series A - Synthex Labs | Valuation |
investors |
|
| Mar, 2017 | Amount | Series A - Synthex Labs | Valuation |
investors |
|
| Oct, 2016 | Amount | Seed - Synthex Labs | Valuation | IndieBio |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Synthex Labs
Synthex Labs has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Synthex Labs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Synthex Labs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synthex Labs Comparisons
Competitors of Synthex Labs
Synthex Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synthex Labs
Frequently Asked Questions about Synthex Labs
When was Synthex Labs founded?
Synthex Labs was founded in 2016.
Where is Synthex Labs located?
Synthex Labs is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Synthex Labs a funded company?
Synthex Labs is a funded company, having raised a total of $10.37M across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Oct 15, 2016.
How many employees does Synthex Labs have?
As of Dec 31, 2024, the latest employee count at Synthex Labs is 15.
What does Synthex Labs do?
Synthex Labs was founded in 2016 and is based in San Francisco, United States. Peptide therapeutics targeting cancer and rare diseases are developed through a proprietary platform involving an engineered microbe. Natural and synthetic peptides are screened to disrupt protein-protein interactions, facilitating drug development for undruggable disorders. The initial focus is on cancers like intrahepatic cholangiocarcinomas, with the lead compound in preclinical testing.
Who are the top competitors of Synthex Labs?
Synthex Labs's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Synthex Labs offer?
Synthex Labs offers Tor FLEx Platform, ToRPPIDO, and ToRNeDO.
Who are Synthex Labs's investors?
Synthex Labs has 1 investor. Key investors include IndieBio.